Antiphospholipid Syndrome Clinical Research Task Force Report.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 219, doi. 10.1177/0961203310395053
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2011 AND VI 20 AND IP 2
Results: 15
1
2
13th International Congress on Antiphospholipid Antibodies (APLA 2010).
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 152, doi. 10.1177/0961203310397413
- By:
- Publication type:
- Article
3
Antiphospholipid antibodies and the brain: A consensus report.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 153, doi. 10.1177/0961203310396748
- By:
- Publication type:
- Article
4
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 206, doi. 10.1177/0961203310395803
- By:
- Publication type:
- Article
5
‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 182, doi. 10.1177/0961203310395055
- By:
- Publication type:
- Article
6
Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 158, doi. 10.1177/0961203310395054
- By:
- Publication type:
- Article
7
‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 191, doi. 10.1177/0961203310397082
- By:
- Publication type:
- Article
8
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 174, doi. 10.1177/0961203310395052
- By:
- Publication type:
- Article
9
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 165, doi. 10.1177/0961203310395051
- By:
- Publication type:
- Article
10
Immunoadsorption (IAS) for systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 115, doi. 10.1177/0961203310389487
- By:
- Publication type:
- Article
11
Review: IL-17-producing T cells in lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 120, doi. 10.1177/0961203310389100
- By:
- Publication type:
- Article
12
Test-retest reliability of hand-held dynamometry and functional tests in systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 144, doi. 10.1177/0961203310388448
- By:
- Publication type:
- Article
13
Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
14
Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 131, doi. 10.1177/0961203310381517
- By:
- Publication type:
- Article
15
Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 125, doi. 10.1177/0961203310378862
- By:
- Publication type:
- Article